Condition

Fibrosing Interstitial Lung Disease clinical trials and research

• 2Clinical trials
• 22Countries

All recruiting trials (2)

• Nerandomilast in children with fibrosing ILD: tolerability and potential benefit

  This study tests whether nerandomilast is safe, tolerable, and helpful for children and teens with fibrosing interstitial lung disease.

  Recruiting at 26 sites Phase 3 Boehringer Ingelheim · Los Angeles, California and 46 other locations · NCT07366034

• Observational study of patients with fibrosing interstitial lung disease in intensive care for respiratory failure

  This study looks at patients with fibrosing lung diseases who end up in intensive care for breathing problems to see how many survive after six months and what factors might affect their chances.

  Recruiting Assistance Publique - Hôpitaux de Paris · Bobigny · NCT06855004

Quick answers

How many Fibrosing Interstitial Lung Disease clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in France (2 trials), Argentina (1 trial), Australia (1 trial), Belgium (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →